A Transplant Athlete's Perspective
Jean Howard-JonesAnn Transplant 2005; 10(4): 57-58 :: ID: 498566
Abstract
My name is Jean Howard-Jones and I was born in Sheffield, U.K. in 1943.
As a schoolgirl I enjoyed sport, playing hockey for the school and swimming for my city and county of Yorkshire until the age of fifteen. Upon graduating from college and after a brief spell in hospital catering, I became Senior Catering Advisor to Birds Eye Foods, a Unilever subsidiary. Following the birth of my daughter, I elected to become a full time mother and my life progressed comfortably until I was diagnosed with polycystic kidney disease in 1991.The diagnosis was a complete shock as traditionally this is a hereditary condition and yet none of my family members had ever experienced renal problems. Consultants advised that I was therefore a new mutant.
Keywords: transplant
In Press
Original article
Fundamental Strategies and Technical Perspectives in Bile Duct Anastomosis for Living Donor Liver Transplan...Ann Transplant In Press; DOI: 10.12659/AOT.953761
Clinical Research
Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cel...Ann Transplant In Press; DOI: 10.12659/AOT.954230
Clinical Research
Prognostic Prediction in Living Donor Liver Transplantation Recipients With Complete Pathological Response ...Ann Transplant In Press; DOI: 10.12659/AOT.954574
Most Viewed Current Articles
24 Aug 2021 : Review article 21,978
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 18,247
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,856
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,762
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604






